March 2021 | Volume 1
Democratization of data is an important concept and it’s heartening to see more movement in the direction of open data for research, greater access for patients directly to their own information and a greater focus on data sharing and interoperability. As with any issue in health, the complexities are myriad. But, the notion that data can be shared and owned by all of us is the right guide-point. There are still some dark corners that require sunlight: pricing data, true cost impacts on patients (beyond just their cost sharing), artificial intelligence algorithms, and clinical pathway development to name a few. In this first month of a new Administration, there has been a refreshing transparency and willingness to learn, seek compromise, and recalibrate as new information emerges. That’s wise thinking about how to improve not only the enterprise of healthcare, but also the actual health of our nation.
Telehealth: The Right Care, at the Right Time, via the Right Medium
The U.S. Centers for Medicare & Medicaid Services expanded coverage for telehealth services in early March 2020 in response to the coronavirus pandemic, prompting many health systems to rapidly transition to virtual care. While telehealth has distinct advantages, widespread adoption also raises concerns regarding clinical appropriateness: When should a patient schedule a telehealth visit versus an in-person visit?
Opinion: To really lower health-care costs, look beyond prescription drugs
There’s a well-known allegory about a man searching for his keys under a lamppost. Although he freely admits to a passing policeman to losing them elsewhere in the darkness, he searches under the lamppost because that’s where the light is.
14 health systems team up on 'ethical innovation' with launch of provider-led data platform
Fourteen health systems, including Trinity Health, Northwell Health and Tenet Health, are partnering to create a comprehensive, de-identified data platform that will glean more robust insights on medical conditions such as rare diseases and COVID-19.
The Health Costs of Cost-Sharing
We use the design of Medicare’s prescription drug benefit program to demonstrate three facts about the health consequences of cost-sharing. First, we show that an as-if-random increase of 33.6% in out-of-pocket price (11.0 percentage points (p.p.) change in coinsurance, or $10.40 per drug) causes a 22.6% drop in total drug consumption ($61.20), and a 32.7% increase in monthly mortality (0.048 p.p.).
As All of Us moves to diversify medicine, its tech partners push to democratize research
Everyone working from home this year has figured out their own ways to stay focused. For Chris Lunt, it’s a squat red sphere he keeps on his desk, painted to depict the furrowed brow of Bodhidharma, the founder of Zen Buddhism — a Daruma doll.
Contributor: Sharpening All the Tools in the Value Assessment Toolbox
The adoption of a German-style drug pricing panel – which relies heavily on comparative clinical research conducted during the first year a drug or other treatment hits the market ­­– is an idea that has captured the interest of President Biden’s health team. While this notion of injecting additional clinical and economic analyses into Medicare’s purchasing decisions is gaining currency, a vital question is left unanswered: What factors are essential to determining a therapy’s fair value?
The money behind mental health: How the pandemic increased innovation, investment in behavioral health care
Earlier this month, Modern Health marked a milestone few companies ever reach: unicorn status.
With the help of its latest $74 million funding round, the startup, which serves as a mental health benefits platform for employers, topped a $1 billion valuation. It has raised a total of $170 million and counts companies like Pixar, Zendesk and Clif Bar as customers.

Passion + Quality = Change That Matters
I embrace the powerful opportunities in our evolving health care landscape. I founded Momentum Health Strategies to be a catalyst for change through continuous learning, diverse engagement and thoughtful policy and practice initiatives. I deliver innovative, strategic thinking and a passion for improving the patient experience. My personal drive and dedication to high-quality results will help you navigate the competitive terrain you face and convert your vision to action.

Momentum Health Strategies

Jennifer L Bright, MPA
(703) 628 - 0534